OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanism of Hedyotis Diffusa in the Treatment of Cervical Cancer
Kai Qian, Dan Fu, Baorui Jiang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Kai Qian, Dan Fu, Baorui Jiang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Showing 18 citing articles:
β-Sitosterol blocks the LEF-1-mediated Wnt/β-catenin pathway to inhibit proliferation of human colon cancer cells
Shengliang Gu, Fahui Liu, Xueheng Xie, et al.
Cellular Signalling (2023) Vol. 104, pp. 110585-110585
Open Access | Times Cited: 22
Shengliang Gu, Fahui Liu, Xueheng Xie, et al.
Cellular Signalling (2023) Vol. 104, pp. 110585-110585
Open Access | Times Cited: 22
Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis
Hui Deng, Jing Jiang, Sisi Zhang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Hui Deng, Jing Jiang, Sisi Zhang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Beta-sitosterol regulates PTGS1 to inhibit gastric cancer cell proliferation and angiogenesis
Jindao Wang, Ming-Hui Zhou, Qiuli Zhou, et al.
Prostaglandins & Other Lipid Mediators (2025), pp. 106964-106964
Closed Access
Jindao Wang, Ming-Hui Zhou, Qiuli Zhou, et al.
Prostaglandins & Other Lipid Mediators (2025), pp. 106964-106964
Closed Access
Exploration of the pharmacological substance basis and efficacy evaluation of Fufang She-She-Cao (Hedyotis diffusa formula) in repressing gastric cancer
Chen Da-hong, Peng-Juan Mao, Wenjing Diao, et al.
Journal of Ethnopharmacology (2025), pp. 119711-119711
Closed Access
Chen Da-hong, Peng-Juan Mao, Wenjing Diao, et al.
Journal of Ethnopharmacology (2025), pp. 119711-119711
Closed Access
Hedyotis diffusa alleviate aflatoxin B1-induced liver injury in ducks by mediating Nrf2 signaling pathway
Pengpeng Wang, Yingli Wang, Tianyi Feng, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 249, pp. 114339-114339
Open Access | Times Cited: 17
Pengpeng Wang, Yingli Wang, Tianyi Feng, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 249, pp. 114339-114339
Open Access | Times Cited: 17
The ketogenic diet could improve the efficacy of curcumin and Oldenlandia diffusa extract in the treatment of gastric cancer by increasing miR340 expression and apoptosis mediated by autophagy, oxidative stress, and angiogenesis
Qiuju Xiao, Bo Deng, Abolfazl Akbari, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Open Access | Times Cited: 14
Qiuju Xiao, Bo Deng, Abolfazl Akbari, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Open Access | Times Cited: 14
Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis
Chengyu Ye, Baofan Zhang, Zhongjie Tang, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111866-111866
Closed Access | Times Cited: 2
Chengyu Ye, Baofan Zhang, Zhongjie Tang, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111866-111866
Closed Access | Times Cited: 2
Hedyotis diffusa–Sculellaria barbata (HD–SB) suppresses the progression of colorectal cancer cells via the hsa_circ_0039933/hsa-miR-204-5p/wnt11 axis
Danye Zhu, Shanmin Yuan, Cong Chen
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Danye Zhu, Shanmin Yuan, Cong Chen
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Network pharmacology, bioinformatics, and experimental validation to identify the role of Hedyotis diffusa willd against gastric cancer through the activation of the endoplasmic reticulum stress
Ling Ou, Mengyang Li, Yan Hou
Heliyon (2024) Vol. 10, Iss. 7, pp. e28833-e28833
Open Access | Times Cited: 1
Ling Ou, Mengyang Li, Yan Hou
Heliyon (2024) Vol. 10, Iss. 7, pp. e28833-e28833
Open Access | Times Cited: 1
Network pharmacology and experimental verification to explore the effect of Hedyotis diffusa on Alzheimer's disease
Jingxu Chen, Jia-Li Rao, Hao Lü, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 1
Jingxu Chen, Jia-Li Rao, Hao Lü, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 1
Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer
Hongyan Wu, Lihu Zhang, Chuntao Wang, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 3
Hongyan Wu, Lihu Zhang, Chuntao Wang, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 3
Asperulosidic Acid Restrains Hepatocellular Carcinoma Development and Enhances Chemosensitivity Through Inactivating the MEKK1/NF-κB Pathway
Liang Li, Huiwen Qiu
Applied Biochemistry and Biotechnology (2023) Vol. 196, Iss. 1, pp. 1-17
Closed Access | Times Cited: 3
Liang Li, Huiwen Qiu
Applied Biochemistry and Biotechnology (2023) Vol. 196, Iss. 1, pp. 1-17
Closed Access | Times Cited: 3
Total flavonoids of Oldenlandia diffusa (Willd.) Roxb. suppresses the growth of hepatocellular carcinoma through endoplasmic reticulum stress-mediated autophagy and apoptosis
Huan Chen, Xiaofei Shang, Huixin Yuan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Huan Chen, Xiaofei Shang, Huixin Yuan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Molecular mechanism of the treatment of lung adenocarcinoma by Hedyotis Diffusa: an integrative study with real-world clinical data and experimental validation
Sheng Wang, Na Yin, Yingyue Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Sheng Wang, Na Yin, Yingyue Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Network Pharmacology Was Used to Predict the Active Components and Prospective Targets of Paeoniae Radix Alba for Treatment in Endometriosis
Yuting Sun, Junhong Cai, Shun Ding, et al.
Reproductive Sciences (2022) Vol. 30, Iss. 4, pp. 1103-1117
Closed Access | Times Cited: 2
Yuting Sun, Junhong Cai, Shun Ding, et al.
Reproductive Sciences (2022) Vol. 30, Iss. 4, pp. 1103-1117
Closed Access | Times Cited: 2
Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma
Cuilan Chen, Ting Liang, Qihui Wu, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 2
Cuilan Chen, Ting Liang, Qihui Wu, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 2
Network Pharmacology and Bioinformatics Identify the Potential Mechanism Underlying the Use of Hedyotis diffusa Willd for Treatment of Rheumatoid Arthritis
Hui Deng, Jing Jiang, Lijuan Wu, et al.
Research Square (Research Square) (2022)
Open Access
Hui Deng, Jing Jiang, Lijuan Wu, et al.
Research Square (Research Square) (2022)
Open Access
Based on Network Pharmacology and Molecular Docking for Research the Hedyotis Diffusa Mechanism on Breast Cancer
li Jun Zhang, Kuan Cao, Lei Deng, et al.
(2022) Vol. 1152, pp. 130-137
Closed Access
li Jun Zhang, Kuan Cao, Lei Deng, et al.
(2022) Vol. 1152, pp. 130-137
Closed Access
